Results concluded that K did better than TK in a variety of situations.
Asher Khan, BS
Advertisement
Articles by Asher Khan, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation
2
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
3
Treating myopia today: US-focused treatments, challenges, and global insights
4
FDA clears BVI’s FineVision HP trifocal IOL for the US market
5
.png "Optometry Times"){kind=logo}
